The aromatherapy service at the Cancer Support and Information Centre
(CSIC) of this regional Cancer Centre has been continually assessed si
nce its inception in 1993. New methods of assessing complementary ther
apies, based on the 'therapy-as-practised', have been explored. The pr
esent study evaluates the service following changes made after an init
ial pilot. The professional aromatherapist developed an evaluation too
l, and formal questionnaires were limited to the Hospital Anxiety and
Depression Scale (HADS). HADS was completed before and after a course
of six aromatherapy sessions. Of 89 patients referred, 58 patients com
pleted the six sessions. Referrals were made by health professionals w
orking in the Cancer Centre and in the CSIC. The majority of patients
were female with breast cancer and were receiving radical oncological
treatment. Tension, stress and anxiety/fear were the most common reaso
ns for referral, and this was reflected in high initial HADS scores. T
here were significant improvements in HADS scores in the 58 patients c
ompleting the course (mean anxiety, depression, and combined scores dr
opped from 8.9 to 6.2, 6.1 to 4.0 and 15.0 to 10.2, respectively, P <
0.001). Fifty per cent or more of the sample reported a significant im
provement in the eight most commonly assessed symptoms. The therapist
was initially cautious about using questionnaires, but she gained conf
idence in using HADS as an assessment tool. The areas covered by her o
wn evaluation tools were broadly comparable to established instruments
such as the EORTC QLQ-C30. We conclude that aromatherapy massage has
a role in reducing psychological distress, and improving symptom contr
ol in cancer patients. Further service evaluation is needed to promote
appropriate referral and effective planning of treatment, and to just
ify cost. Given the multifaceted nature of complementary therapies, th
e need to develop new research methodologies is acknowledged.